Skip to content

DR. D. FRANS

Active Private limited companyfounded 2006active for 20 yearsRidder Dessainlaan 25, 2800 MechelenKBO/BCE: BE 0880.916.683

Lifetime

20 annual accounts with figures on one time axis
peak of €125,288 in 2021
€92,472▼ 12.3%
peak of €71,144 in 2021
€49,525▼ 11.6%
peak of €360,490 in 2025
€360,490▲ 15.9%
€16,612▼ 30.5%
Board1 name since 2016
1 director
Documentsfilings and deeds
30-07-20261 day before the deadline
2025abbreviated format
Gross margin from €105,403 to €92,472Equity from €310,965 to €360,490Debts from €23,901 to €16,612Cash from €18,981 to €65,846

Key points

from the 2025 annual accounts

Equity

€360,490 ▲ 15.9%

DR. D. FRANS has made a profit in every financial year since 2006.

Liquidity

19.98 was 8.31 in 2024

Short-term debts fell from €22,668 to €12,555.

Filings

20 annual accounts since 2006
AprilJune31 JulyOctober2010201520202025

Eight of the last ten came late. The 2019 accounts came in latest, 131 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,390 companies had the same profile as DR. D. FRANS has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,390 companies, not a prediction for DR. D. FRANS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 17-11-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0880916683
appointed as director “De uitoefening van de geneeskunde, in het bijzonder de huisartsengeneeskunde, door de arts-vennoten in naam en…” (deed in Dutch) · 200 shares · Gazette deed
Registered office moved to Mechelen The registered office moved to Ridder Dessainlaan 25 2800 Mechelen · Board meeting of 26-03-2018 · Gazette deed
reappointed as manager General meeting of 17-06-2016 · Gazette deed
All 35 events

Comparable companies

same main activity, similar in size and age
Company
DR. D. FRANS Mechelen €377,102 €92,472 95.6% -
DR. HELENA PEETERS Antwerp €404,705 €99,020 95.7% -
Dokter Didier Coens Antwerp €393,009 €91,494 97.8% -
Dokter Gertie Vijgen Wuustwezel €330,696 €91,395 70.4% -
MEDI ANH Enghien €384,661 €93,587 38.7% -
Docteurs PASQUAZZO-LANGEN Arlon €369,449 €97,514 70.1% -
DR. SCHELLEKENS VIRGINIE Brussels €387,027 €97,534 92.9% -

These companies have the same main activity as DR. D. FRANS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €331,000 and €405,000, founded between 2007 and 2008.

Official details

Source: KBO
Status
Active since 12-04-2006Normal situation
Activity
General medical practiceNACE 86210and 1 other
Establishment unit
2.234.841.4952800 Mechelen, since 12-04-2006
Financial year end
31 December
Peppol
Reachable since 06-01-2026
Company details

Annual accounts 2025

≈ €220,000estimated
€377,102▲ 12.6%
Filing
Filed on 30-07-2026, 1 day before the end of the filing period
Financials

Insights on DR. D. FRANS

DR. D. FRANS files the abbreviated format. That format states no turnover. The gross margin rose from €22,222 in 2006 to €92,472 in 2025.

The balance sheet grew most from 2015 to 2017 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. D. FRANS

What is the company number of DR. D. FRANS?
The company number of DR. D. FRANS is 0880.916.683. The VAT number is the same number with BE in front: BE 0880.916.683.
Where is DR. D. FRANS based?
The registered office is at Ridder Dessainlaan 25, 2800 Mechelen.Company details
What does DR. D. FRANS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. D. FRANS?
DR. D. FRANS is a private limited company (BV).
When was DR. D. FRANS founded?
DR. D. FRANS was founded on 12-04-2006.
Is DR. D. FRANS still active?
Yes, DR. D. FRANS is an active enterprise in the KBO register.
What is the turnover of DR. D. FRANS?
The turnover in financial year 2025 is about €220,000. This figure is estimated from the gross margin of €92,472 and 46 comparable companies (NACE 862). It probably lies between €160,000 and €340,000.Financials
Is DR. D. FRANS profitable?
In financial year 2025, DR. D. FRANS made a profit of €49,525.
Where can I find the annual accounts of DR. D. FRANS?
DR. D. FRANS filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. D. FRANS due?
DR. D. FRANS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.